Table 2.
Variants in 37 DSD-related genes identified in 35 patients with 46,XY DSD.
ID | Sex# | DSD category | Clinical diagnosis | DSD gene | Inheritance | GnomAD frequency | DNA change | Protein change | SIFT | MT | ACGM classification |
---|---|---|---|---|---|---|---|---|---|---|---|
4 | M | DGD | TRS | POR | AR | 0.25% | c.683C>T | p.Pro228Leu | D | D | VUS |
9 | F | DGD | CGD | AR | XL | (CAG)28 | VUS | ||||
11 | M | DAS | 5αRD | HOXA13 | AD | c.539C>T | p.Pro180Leu | D | D | Likely pathogenic | |
ARX | XL | 0.00% | c.1315_1320dupGCCGCC | p.Ala439delinsGlyArgPro | VUS | ||||||
12 | M | DAS | 5αRD | AMH | AR | 0.01% | c.1013G>A | p.Arg338His | D | T | VUS |
AKR1C4 | AR | 0.00% | c.467A>C | p.Asp156Ala | D | D | VUS | ||||
13 | F | DAS | DAS | HSD17B3 | AR | 0.01% | c.729_735delGATAACC | p.Ile244Argfs*11 | Pathogenic | ||
HSD17B3 | AR | 0.03% | c.277+4A>T | Pathogenic | |||||||
CYP17A1 | AR | c.666+5G>A | VUS | ||||||||
14 | M | DAA | NSDUM | WT1 | AD | c.605T>G | p.Leu202Arg | D | U | Likely pathogenic | |
15 | M | DAA | NSDUM | AR | XL | c.2199C>A | p.Asp733Glu | D | D | Pathogenic | |
SOX9 | AD | c.847A>G | p.Ile283Val | D | D | VUS | |||||
POR | AR | 0.01% | c.1586C>T | p.Thr529Met | D | D | VUS | ||||
16 | M | DAA | NSDUM | HSD17B3 | AR | 0.01% | c.729_735delGATAACC | p.Ile244Argfs*11 | VUS | ||
18 | M | DAA | NSDUM | CBX2 | AR | c.460delT | p.Cys154Alafs*62 | VUS | |||
AR | XL | (CAG)28 | VUS | ||||||||
20 | F | DAA | CAIS | AR | XL | c.1715A>G | p.Tyr572Cys | D | D | Pathogenic | |
21 | F | DAA | CAIS | AR | XL | c.2086G>A | p.Asp696Asn | D | D | Pathogenic | |
22 | F | DAA | CAIS | AR | XL | c.2546dupA | p.Asn849Lysfs*32 | Pathogenic | |||
23 | F | DAA | CAIS | AR | XL | c.2222C>A | p.Ser741Tyr | D | D | Pathogenic | |
POR | AR | 0.03% | c.571G>C | p.Val191Leu | T | D | VUS | ||||
24 | F | DAA | CAIS | AR | XL | c.1822C>T | p.Arg608* | U | D | Pathogenic | |
25 | F | DAA | CAIS | AR | XL | c.2222C>T | p.Ser741Phe | D | D | Pathogenic | |
26 | F | DAA | CAIS | AR | XL | c.2086G>A | p.Asp696Asn | D | D | Pathogenic | |
DHCR7 | AR | 0.01% | c.89G>C | p.Gly30Ala | D | D | VUS | ||||
27 | F | DAA | PAIS | NR5A1 | AR;AD | c.274C>T | p.Arg92Trp | D | D | Pathogenic | |
32 | M | sDSD | sDSD | STAR | AR | c.65-2A>T | VUS | ||||
33 | M | sDSD | sDSD | AR | XL | (CAG)29 | VUS | ||||
34 | M | sDSD | sDSD | AR | XL | (CAG)29 | VUS | ||||
DMRT1 | AD | 0.26% | c.671A>G | p.Asn224Ser | D | D | VUS |
All variants listed are heterozygous, with the exception of changes in AR and ARX, which are hemizygous as these genes are on the X chromosome. The number of CAG repeats leading to the expansion of the polyglutamine tract in the AR gene is specified with the index number.
#Sex of rearing.
5αRD, 5α-reductase deficiency; ACMG, American College of Medical Genetics and Genomics; AD, autosomal dominant; AR, autosomal recessive; CAIS, complete androgen insensitivity syndrome; CGD, complete gonadal dysgenesis; D, deleterious; DAA, disorder of androgen action; DAS, disorder of androgen synthesis; DGD, disorder of gonadal development; DSD, disorder of sex development; F, female; GnomAD, Genome Aggregation Database; M, male; MT, MutationTaster; NSDUM, nonspecific disorder of undermasculinization; PAIS, partial androgen insensitivity syndrome; sDSD, syndromic disorder of sex development; SIFT, Sorting Intolerant From Tolerant; T; tolerated; TRS, testicular regression syndrome; U, unknown; VUS, variant of uncertain significance; XL, X-linked.